Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Behavioral Medicine
Published in: Annals of Behavioral Medicine 1/2011

01-08-2011 | Original Article

Sexual HIV Transmission and Antiretroviral Therapy: A Prospective Cohort Study of Behavioral Risk Factors Among Men and Women Living with HIV/AIDS

Authors: Seth C. Kalichman, PhD, Chauncey Cherry, MPH, Denise White, MA, Miche’l Jones, MA, Tamar Grebler, BA, Moira O. Kalichman, MSW, Mervi Detorio, MS, Angela M. Caliendo, MD, PhD, Raymond F. Schinazi, PhD

Published in: Annals of Behavioral Medicine | Issue 1/2011

Login to get access

Abstract

Background

Using antiretroviral therapies for HIV prevention relies on patient adherence and avoidance of co-occurring sexually transmitted infections.

Purpose

The objective of this study is to simultaneously examine HIV treatment adherence and sexual risks for HIV transmission.

Methods

This study is a prospective cohort of 201 men and 55 women diagnosed with HIV/AIDS infection.

Results

A total of 32% men and 39% women engaged in unprotected intercourse with at least one HIV negative or unknown HIV status sex partner over 12 months. Nearly half (46%) of participants with HIV negative or unknown HIV status unprotected sex partners had detectable HIV viral load and were significantly more likely to have contracted a sexually transmitted infection since their HIV diagnosis. Individuals at higher risk for transmitting HIV were also less adherent to antiretroviral therapies.

Conclusions

Programs that aim to use antiretroviral therapies for HIV prevention require careful attention to adherence, sexually transmitted co-infections, and substance use.
Literature
1.
2.
Grant RM, Lama JR, Anderson PL et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Eng J Med, 2010; epub ahead of print, November 23, 2010.
3.
Kashuba AD, Dyer JR, Kramer L, Raasch R, Eron J, Cohen M. Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob Agents Chemotherther, 1999;43(8): 1817–26.
4.
Donnell D, Baeteb JM, Kiarie J, Thomas K, Stevens W, Cohen C, MCIntyre J, Lingappa J, Celum C. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 2010;375:2092–98.PubMedCrossRef
5.
Quinn TC, Wawer M, Sewankambo MB, Serwadda D, Li C, Wabwire-Mangen F, et al. et al., Viral load and heterosexual transmission of human immunodeficiency virus type 1. New England Journal of Medicine, 2000; 342: 921–929.PubMedCrossRef
6.
Granich RM, Gilks CF, Dye C, DeCock K, Williams B. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model. Lancet, 2009; 373(9657):48–57.PubMedCrossRef
7.
Lima, V.D., Hogg, RS, Montaner JS. Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada. PLoS ONE, 2010; 5(6):e10991.PubMedCrossRef
8.
Vernazza P, Hirschel B, Bernasconi E, Flepp M, HIV-positive individuals without additional sexually transmitted diseases (STD) and on effective anti-retroviral therapy are sexually non-infectious. Bull des médecins suisses 2008; 89:5.
9.
Hasse B, Ledergerber B, Hischel B, Vernazza P, Glass T, Jeannin A, et al. Frequency and Determinants of Unprotected Sex among HIV-Infected Persons: The Swiss HIV Cohort Study. Clin Inf Dis, 2010; 51(11):1314–1322.CrossRef
10.
De Cock KM, et al., Can antiretroviral therapy eliminate HIV transmission? Lancet, 2009;373(9657):7–9.PubMedCrossRef
11.
Dieffenbach CW, Fauci, A. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA, 2009;301(22):2380–2.PubMedCrossRef
12.
Garnett GP, Baggaley R. Treating our way out of the HIV pandemic: Could we, would we, should we? Lancet, 2009; 373(9657):9–11.PubMedCrossRef
13.
Wagner B, Blower S. Costs of eliminating HIV in South Africa have been underestimated. Lancet, 2010;376(9745):953–4.PubMedCrossRef
14.
Wagner B, Kahn J, Blower S. Should we try to eliminate HIV epidemics by using a ‘Test and Treat’ strategy? AIDS 2010; 24(5):775–6.PubMedCrossRef
15.
Celum, C., et al., Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. New Eng J Med 2010; 362(5):427–39.PubMedCrossRef
16.
Cohen MS, et al., Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997;349:1868–1873.PubMedCrossRef
17.
Mills EJ, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006; 296(6):679–90.PubMedCrossRef
18.
Kalichman SC, Eaton L, Cherry C et al. Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: Implications for HIV treatment as prevention. HIV Med 2010; 11:502–9.PubMed
19.
Shuper PA, et al., Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: Review and meta-analysis. AIDS Behav, 2009;13(6): 1021–36.PubMedCrossRef
20.
Theall KP, et al., Alcohol consumption, ART usage and high-risk sex among women infected with HIV. AIDS Behav, 2007;11(2):205–15.PubMedCrossRef
21.
Amico KR, et al., The Information-Motivation-Behavioral Skills Model of ART adherence in a deep south HIV+ clinic sample. AIDS Behav 2009;13(1):66–75.PubMedCrossRef
22.
Hendershot CS, et al. Alcohol use and antiretroviral adherence: Review and meta-analysis. JAIDS, 2009; 52(2):180–202.PubMedCrossRef
23.
Baliunas D, et al. Alcohol consumption and risk of incident human immunodeficiency virus infection: A meta-analysis. Internat J Public Health 2010; 55(3):159–66.CrossRef
24.
Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Inf 2003;79(1) 59–61.CrossRef
25.
Diamond C, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. JAIDS 2005;39: 211–218.PubMed
26.
Kalichman SC. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: Implications for positive prevention interventions. Psychosom Med 2008; 70(5):593–7.PubMedCrossRef
27.
Kalichman SC, Rompa, D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. J Nervous Mental Dis 2000;188(10):662–70.PubMedCrossRef
28.
Baggaley RF, White, RG, Boily MC. HIV transmission risk through anal intercourse: Systematic review, meta-analysis and implications for HIV prevention. Internat J Epid 2010;39(4):1048–63.CrossRef
29.
Napper LE, Fisher D, Reynolds G, Johnson M. HIV Risk Behavior Self-Report Reliability at Different Recall Periods. AIDS Behav 2010;14:15–61.CrossRef
30.
Bangsberg DR, et al. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS Behav 2001;5:275–281.CrossRef
31.
Kalichman SC, et al. Monitoring Antiretroviral adherence by unannounced pill counts conducted by telephone: Reliability and criterion-related validity. HIV Clinical Trials 2008;9:298–308.PubMedCrossRef
32.
Kalichman SC, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen Internal Med 2007; 22: 1003–6.PubMedCrossRef
33.
Granich R, et al. Highly active antiretroviral treatment as prevention of HIV transmission: Review of scientific evidence and update. Cur Opinions HIV AIDS, 2010; 5(4):298–304.CrossRef
34.
Engsig F, et al., Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months. HIV Med 2010; 11:457–461.PubMed
35.
Das M, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE, 2010; 5(6): e11068.PubMedCrossRef
36.
Deeks SG, et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infectious Dis 2009; 49(10):1582–90.PubMedCrossRef
37.
Parienti JJ, et al. Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE 2008; 3(7):e2783.PubMedCrossRef
38.
Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clinical Infectious Diseases, 2010; 50 Suppl 3:S85-95.PubMedCrossRef
39.
Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis. Sex Transm Dis 2008; 35(11): 946–59.PubMedCrossRef
40.
Simoni JM, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. JAIDS 2006; 43 Suppl 1: S23-35.PubMedCrossRef
41.
Crepaz N, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS 2006; 20(2):143–57.PubMedCrossRef
42.
Johnson BT, et al. Behavioral interventions for African Americans to reduce sexual risk of HIV: A meta-analysis of randomized controlled trials. JAIDS 2009; 51(4):492–501.PubMedCrossRef
Metadata
Title
Sexual HIV Transmission and Antiretroviral Therapy: A Prospective Cohort Study of Behavioral Risk Factors Among Men and Women Living with HIV/AIDS
Authors
Seth C. Kalichman, PhD
Chauncey Cherry, MPH
Denise White, MA
Miche’l Jones, MA
Tamar Grebler, BA
Moira O. Kalichman, MSW
Mervi Detorio, MS
Angela M. Caliendo, MD, PhD
Raymond F. Schinazi, PhD
Publication date
01-08-2011
Publisher
Springer-Verlag
Published in
Annals of Behavioral Medicine / Issue 1/2011
Print ISSN: 0883-6612
Electronic ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-011-9271-3

Other articles of this Issue 1/2011

Annals of Behavioral Medicine 1/2011 Go to the issue

Original Article

Children with Diabetes Compared to Peers: Depressed? Distressed?

Letter to the Editor

Are Couple-Oriented Interventions Effective Across Chronic Illnesses?: A Reply to Arthurs and Colleagues

Rapid Communication

Determinants of Physical Activity Among People with Spinal Cord Injury: A Test of Social Cognitive Theory

Erratum

Erratum to: New Methods for Tobacco Dependence Treatment Research

Original Article

Efficacy of the Survivor Health and Resilience Education (SHARE) Program to Improve Bone Health Behaviors Among Adolescent Survivors of Childhood Cancer

Original Article

Reviewing Manuscripts for Peer-Review Journals: A Primer for Novice and Seasoned Reviewers